- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
K.2: 4 residues within 4Å:- Chain A: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.345, A:Q.501, A:F.503, H2O.2, H2O.17
K.8: 4 residues within 4Å:- Chain B: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.345, B:Q.501, B:F.503, H2O.24, H2O.39
K.14: 4 residues within 4Å:- Chain C: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.345, C:Q.501, C:F.503, H2O.45, H2O.61
K.20: 4 residues within 4Å:- Chain D: Q.338, D.345, Q.501, F.503
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.345, D:Q.501, D:F.503, H2O.67, H2O.83
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 5 residues within 4Å:- Chain A: D.545, N.572, E.574, G.576
- Ligands: TP9.4
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.545, A:E.574, H2O.3
MG.9: 5 residues within 4Å:- Chain B: D.545, N.572, E.574, G.576
- Ligands: TP9.10
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.545, B:E.574, H2O.25
MG.15: 5 residues within 4Å:- Chain C: D.545, N.572, E.574, G.576
- Ligands: TP9.16
3 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.545, C:E.574, H2O.47
MG.21: 5 residues within 4Å:- Chain D: D.545, N.572, E.574, G.576
- Ligands: TP9.22
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.545, D:E.574, H2O.69
- 4 x TP9: (3Z)-4-{[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]AMINO}-3-MERCAPTOPENT-3-EN-1-YL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
TP9.4: 27 residues within 4Å:- Chain A: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain D: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Ligands: MG.3, CO2.6
22 PLIP interactions:8 interactions with chain D, 14 interactions with chain A- Hydrophobic interactions: D:Y.108, D:T.157, D:P.160, A:M.520, A:Q.575
- Hydrogen bonds: D:Q.197, A:Q.494, A:H.495, A:G.518, A:M.520, A:D.545, A:A.546, A:S.547, A:N.572, A:G.576, A:M.577
- Water bridges: D:G.111, D:G.111, D:E.134, D:Q.197
- Salt bridges: A:H.495, A:H.495
TP9.10: 27 residues within 4Å:- Chain B: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Chain C: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Ligands: MG.9, CO2.12
22 PLIP interactions:14 interactions with chain B, 8 interactions with chain C- Hydrophobic interactions: B:M.520, B:Q.575, C:Y.108, C:T.157, C:P.160
- Hydrogen bonds: B:Q.494, B:H.495, B:G.518, B:M.520, B:D.545, B:A.546, B:S.547, B:N.572, B:G.576, B:M.577, C:Q.197
- Salt bridges: B:H.495, B:H.495
- Water bridges: C:G.111, C:G.111, C:E.134, C:Q.197
TP9.16: 27 residues within 4Å:- Chain B: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Chain C: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.15, CO2.18
21 PLIP interactions:14 interactions with chain C, 7 interactions with chain B- Hydrophobic interactions: C:M.520, C:Q.575, B:Y.108, B:T.157, B:P.160
- Hydrogen bonds: C:Q.494, C:H.495, C:G.518, C:M.520, C:D.545, C:A.546, C:S.547, C:N.572, C:G.576, C:M.577, B:Q.197
- Salt bridges: C:H.495, C:H.495
- Water bridges: B:G.111, B:G.111, B:Q.197
TP9.22: 27 residues within 4Å:- Chain A: Y.108, A.109, G.110, E.134, T.157, P.160, N.164, Q.197
- Chain D: V.492, G.493, Q.494, H.495, G.518, M.520, G.544, D.545, A.546, S.547, M.550, N.572, E.574, Q.575, G.576, M.577, V.578
- Ligands: MG.21, CO2.24
21 PLIP interactions:7 interactions with chain A, 14 interactions with chain D- Hydrophobic interactions: A:Y.108, A:T.157, A:P.160, D:M.520, D:Q.575
- Hydrogen bonds: A:Q.197, D:Q.494, D:H.495, D:G.518, D:M.520, D:D.545, D:A.546, D:S.547, D:N.572, D:G.576, D:M.577
- Water bridges: A:G.111, A:G.111, A:Q.197
- Salt bridges: D:H.495, D:H.495
- 4 x H4V: methyl 2-{[(4-iodo-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl}benzoate(Non-covalent)
H4V.5: 18 residues within 4Å:- Chain A: M.349, D.374, R.375, M.577, V.578, W.581, A.652
- Chain D: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Ligands: FAD.1, CO2.6
13 PLIP interactions:8 interactions with chain D, 5 interactions with chain A- Hydrophobic interactions: D:V.186, D:P.187, D:A.190, D:A.195
- Hydrogen bonds: D:K.246, D:K.246, D:K.246, A:R.375, A:R.375
- Salt bridges: D:K.246
- pi-Stacking: A:W.581, A:W.581
- pi-Cation interactions: A:R.375
H4V.11: 18 residues within 4Å:- Chain B: M.349, D.374, R.375, M.577, V.578, W.581, A.652
- Chain C: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Ligands: FAD.7, CO2.12
13 PLIP interactions:8 interactions with chain C, 5 interactions with chain B- Hydrophobic interactions: C:V.186, C:P.187, C:A.190, C:A.195
- Hydrogen bonds: C:K.246, C:K.246, C:K.246, B:R.375, B:R.375
- Salt bridges: C:K.246
- pi-Stacking: B:W.581, B:W.581
- pi-Cation interactions: B:R.375
H4V.17: 18 residues within 4Å:- Chain B: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Chain C: M.349, D.374, R.375, M.577, V.578, W.581, A.652
- Ligands: FAD.13, CO2.18
13 PLIP interactions:5 interactions with chain C, 8 interactions with chain B- Hydrogen bonds: C:R.375, C:R.375, B:K.246, B:K.246, B:K.246
- pi-Stacking: C:W.581, C:W.581
- pi-Cation interactions: C:R.375
- Hydrophobic interactions: B:V.186, B:P.187, B:A.190, B:A.195
- Salt bridges: B:K.246
H4V.23: 18 residues within 4Å:- Chain A: G.111, A.112, V.186, P.187, A.190, A.195, F.196, Q.197, K.246
- Chain D: M.349, D.374, R.375, M.577, V.578, W.581, A.652
- Ligands: FAD.19, CO2.24
13 PLIP interactions:8 interactions with chain A, 5 interactions with chain D- Hydrophobic interactions: A:V.186, A:P.187, A:A.190, A:A.195
- Hydrogen bonds: A:K.246, A:K.246, A:K.246, D:R.375, D:R.375
- Salt bridges: A:K.246
- pi-Stacking: D:W.581, D:W.581
- pi-Cation interactions: D:R.375
- 4 x CO2: CARBON DIOXIDE(Non-covalent)
CO2.6: 6 residues within 4Å:- Chain A: V.492, M.577
- Chain D: Q.197
- Ligands: FAD.1, TP9.4, H4V.5
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:Q.197
- Water bridges: D:G.111
CO2.12: 6 residues within 4Å:- Chain B: V.492, M.577
- Chain C: Q.197
- Ligands: FAD.7, TP9.10, H4V.11
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:Q.197
- Water bridges: C:G.111
CO2.18: 6 residues within 4Å:- Chain B: Q.197
- Chain C: V.492, M.577
- Ligands: FAD.13, TP9.16, H4V.17
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Q.197
- Water bridges: B:G.111
CO2.24: 6 residues within 4Å:- Chain A: Q.197
- Chain D: V.492, M.577
- Ligands: FAD.19, TP9.22, H4V.23
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.197
- Water bridges: A:G.111
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)
- 4 x K: POTASSIUM ION(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x TP9: (3Z)-4-{[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]AMINO}-3-MERCAPTOPENT-3-EN-1-YL TRIHYDROGEN DIPHOSPHATE(Non-covalent)
- 4 x H4V: methyl 2-{[(4-iodo-6-methoxypyrimidin-2-yl)carbamoyl]sulfamoyl}benzoate(Non-covalent)
- 4 x CO2: CARBON DIOXIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Garcia, M.D. et al., Commercial AHAS-inhibiting herbicides are promising drug leads for the treatment of human fungal pathogenic infections. Proc. Natl. Acad. Sci. U.S.A. (2018)
- Release Date
- 2018-09-26
- Peptides
- Acetolactate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A